In part 3 of a Spotlight special series on the role of new weight loss medicines like Ozempic in South Africa, we ask what these breakthrough jabs might mean for people living with HIV in the country. There is some tantalising early research on potential benefits, but also many uncertainties. Catherine Tomlinson reports.
Funding cuts over the last year or so have created a crisis for multilateral health institutions. Which institutions emerge from this crisis, and in what form, will have real consequences for the health of people in South Africa, argues Spotlight editor Marcus Low.
In South Africa, access to weight loss medicines like Ozempic and Mounjaro remains limited to those who can shell out a few thousand Rand a month. In the second article of a Spotlight special series, Catherine Tomlinson looks at the medical need for these medicines in the country and what it would take for government to provide them in the public sector.
District managers in South Africa’s public healthcare system currently have to juggle funding from multiple government budget lines, each with different strings attached. To improve district health services, we urgently need to simplify and integrate these funding flows, argues Russell Rensburg.
Hypertension is poorly managed in South Africa. Remarkable findings from a study in rural KwaZulu-Natal suggest a compelling alternative to the current model of clinic-based care – using community healthcare workers to monitor people’s blood pressure in their own homes. Elri Voigt reports.
While the 2025 national budget boosts health spending, researchers from the South African Medical Research Council stress the need for strong accountability measures. They also raise concerns about rising VAT and omissions related to US funding cuts and climate change.
Non-communicable diseases are killing more and more people in South Africa yet the government missed out on raising a total of more than R15 billion for prevention efforts, argues Dr Evelyn Thsehla.
The 2024 national budget offer some glimmers but allocations for direct health benefits fall short of making a difference to people’s health and wellbeing. These include a ring-fenced allocation to crack down on corruption in health to inspire trust for the National Health Insurance, taxing accessories for e-cigarettes, a jacked up child-support grant, clarity on plans dealing with climate change and its impacts on human health, and finally greater investment to enhance women’s capabilities alongside the Covid-19 grant, researchers from the South African Medical Research Council write exclusively for Spotlight.
Doing ‘the right thing’ for one’s health, be it eating well, exercising, or going for an annual HIV test or blood pressure check, is easier said than done. One way to nudge people to make these ‘right’ decisions is to offer rewards or incentives. Amy Green asks whether aspects of some popular private-sector incentive schemes might be worth copying in South Africa’s public sector.
Experts describe rising obesity rates in South Africa as an “urgent crisis”, “a tsunami” – even an “epidemic” – that is costing lives, not to mention billions of rands. Tackling the situation warrants an action plan that is as comprehensive and cogent as the problem is dire. But does the new national strategy fit the bill? Amy Green asked several local experts.
South Africa’s National Strategic Plan for NCDs sets three key targets related to hypertension that the country has to achieve to reduce the burden of hypertension in the country. Elri Voigt asks experts how South Africa is performing against these targets and where improvement is most needed.
Obesity is a complicated public health issue that can be devastating on both the societal and the individual level. New weight loss medicines have shown remarkable efficacy in clinical trials, but their high cost is limiting uptake. Amy Green asks where these new medicines should fit into South Africa’s response to rising levels of obesity.
